P909-5132 Screening compound: {(3R,4R)-3-methyl-4-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]tetrahydro-1H-pyrrol-1-yl}(1-phenylcyclopropyl)methanone

P909-5132 Screening compound: {(3R,4R)-3-methyl-4-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]tetrahydro-1H-pyrrol-1-yl}(1-phenylcyclopropyl)methanone
P909-5132 Screening compound: {(3R,4R)-3-methyl-4-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]tetrahydro-1H-pyrrol-1-yl}(1-phenylcyclopropyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound P909-5132
{(3R,4R)-3-methyl-4-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]tetrahydro-1H-pyrrol-1-yl}(1-phenylcyclopropyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P909-5132

Molecular Formula

C22H22N4O2 (C22 H22 N4 O2)

Compound Name

{(3R,4R)-3-methyl-4-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]tetrahydro-1H-pyrrol-1-yl}(1-phenylcyclopropyl)methanone

IUPAC name

3-{5-[(3R4R)-4-methyl-1-(1-phenylcyclopropanecarbonyl)pyrrolidin-3-yl]-124-oxadiazol-3-yl}pyridine

SMILES

C[C@@H](CN(C1)C(C2(CC2)c2ccccc2)=O)[C@H]1c1nc(-c2cnccc2)no1

InChI

InChI=1S/C22H22N4O2/c1-15-13-26(21(27)22(9-10-22)17-7-3-2-4-8-17)14-18(15)20-24-19(25-28-20)16-6-5-11-23-12-16/h2-8,11-12,15,18H,9-10,13-14H2,1H3/t15-,18-/m1/s1

InChI Key

GPLOLIWHXBQHKI-CRAIPNDOSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

374.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.219

Distribution Coefficient, logD

2.581

Water Solubility, LogSw

-3.33

Polar Surface Area

58.295

Acid Dissociation Constant (pKa)

21.04

Base Dissociation Constant (pKb)

7.93

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

36.36

P909-5132 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with P909-5132 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P909-5132?
Check Price and Availability of P909-5132, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P909-5132 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P909-5132
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P909-5132
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P909-5132 available by request